The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9428478, TG6-190 ID: ALA3979526
PubChem CID: 71116724
Max Phase: Preclinical
Molecular Formula: C23H25N3O3
Molecular Weight: 391.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(N2CCN(C(=O)c3[nH]c4ccc(C(C)=O)cc4c3C)CC2)cc1
Standard InChI: InChI=1S/C23H25N3O3/c1-15-20-14-17(16(2)27)4-9-21(20)24-22(15)23(28)26-12-10-25(11-13-26)18-5-7-19(29-3)8-6-18/h4-9,14,24H,10-13H2,1-3H3
Standard InChI Key: KNBHCSFZFNPVBO-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
13.6508 -3.3324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0576 -4.3755 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5568 -4.3862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8134 -5.6890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3134 -5.6966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5567 -4.4014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3002 -3.0986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8002 -3.0910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0560 -4.4066 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3105 -5.7083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8105 -5.7135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0559 -4.4171 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8014 -3.1154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3014 -3.1102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5551 -4.4192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9569 -5.4595 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8032 -3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4133 -1.7530 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3114 -2.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4916 -3.8582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 1.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6387 0.8962 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.6024 2.6977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
6 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 9 1 0
12 15 1 0
15 16 2 0
15 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
24 25 1 0
25 17 2 0
25 26 1 0
22 27 1 0
27 28 2 0
27 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 391.47Molecular Weight (Monoisotopic): 391.1896AlogP: 3.65#Rotatable Bonds: 4Polar Surface Area: 65.64Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.99CX LogP: 2.94CX LogD: 2.94Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.69Np Likeness Score: -1.19
References 1. (2016) Piperazine derivatives, compositions, and uses related thereto,